Use of clomiphene citrate in infertile women: a committee opinion

Practice Committee of the American Society for Reproductive Medicine

doi:10.1016/j.fertnstert.2013.05.033

Use of clomiphene citrate in infertile women: a committee opinion

Fertil Steril. 2013 Aug;100(2):341-8. doi: 10.1016/j.fertnstert.2013.05.033. Epub 2013 Jun 27.

Author

Practice Committee of the American Society for Reproductive Medicine¹

Collaborators

Practice Committee of the American Society for Reproductive Medicine:
Samantha Pfeifer, Marc Fritz, Roger Lobo, R Dale McClure, Jeffrey Goldberg, Michael Thomas, Margareta Pisarska, Eric Widra, Glenn Schattman, Mark Licht, Jay Sandlow, John Collins, Marcelle Cedars, Mitchell Rosen, Michael Vernon, Catherine Racowsky, Owen Davis, Daniel Dumesic, Randall Odem, Kurt Barnhart, Clarisa Gracia, William Catherino, Robert Rebar, Andrew La Barbera

Affiliation

¹ American Society for Reproductive Medicine, Birmingham, Alabama 35216, USA. [email protected]

PMID: 23809505
DOI: 10.1016/j.fertnstert.2013.05.033

Abstract

This committee opinion describes the use of clomiphene citrate, including indications, use, monitoring, and side effects. There is also a discussion of adjuvants and alternatives to clomiphene citrate therapy.

MeSH terms

Clomiphene / adverse effects
Clomiphene / pharmacology
Clomiphene / therapeutic use*
Combined Modality Therapy
Contraindications
Ethics Committees, Clinical
Expert Testimony
Female
Fertility Agents, Female / adverse effects
Fertility Agents, Female / pharmacology
Fertility Agents, Female / therapeutic use*
Gonadotropins / therapeutic use
Humans
Infertility, Female / diagnosis
Infertility, Female / drug therapy*
Pregnancy
Pregnancy Outcome
Reproductive Techniques, Assisted / ethics
Standard of Care

Substances

Fertility Agents, Female
Gonadotropins
Clomiphene